Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion

Pharm Res. 2017 Oct;34(10):2211-2222. doi: 10.1007/s11095-017-2228-x. Epub 2017 Jul 24.

Abstract

Purpose: Progesterone (PRG) was selected as a model drug to develop a long-acting injection system for poorly water-soluble drugs.

Methods: Microspheres with high density-low porosity were prepared by hot-melt extrusion (HME) combined with wet-milling as the representative formulation, and a microcrystal suspension was also studied as a comparison. The morphology, particle size and distribution, polymorphism, drug distribution, density and porosity were characterized by scanning electron microscopy, laser diffraction particle size analyzer, power X-ray diffraction and DSC respectively. The in vivo performance of the different formulations within 7 days after intramuscular injection was evaluated in male SD rats.

Results: The drug-loading rate of the microspheres could be as high as 40%. The average initial burst release of the microspheres (PLGA lactide:glycolide = 75:25) was only 6.7% much lower than that of the microsuspension (25.7%) and a sustained release was exhibited for at least 7 days. The release mechanism was speculated to be as follows. The microspheres are a drug depot with drug microcrystals in the PLGA matrix which is a layer by layer honeycomb structure.

Conclusions: Microspheres prepared by HME combined with wet-milling could achieve a long-term sustained release effect as a novel long-acting formulation strategy.

Keywords: HME; PLGA; in vivo; microsphere; progesterone.

MeSH terms

  • Animals
  • Chemistry, Pharmaceutical
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / chemistry
  • Delayed-Action Preparations / pharmacokinetics*
  • Drug Carriers / chemistry*
  • Drug Liberation
  • Humans
  • Lactic Acid / chemistry*
  • Male
  • Microspheres
  • Particle Size
  • Polyglycolic Acid / chemistry*
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Porosity
  • Progesterone / administration & dosage
  • Progesterone / chemistry
  • Progesterone / pharmacokinetics*
  • Rats
  • Rats, Sprague-Dawley
  • Solubility
  • Surface Properties

Substances

  • Delayed-Action Preparations
  • Drug Carriers
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Progesterone